{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T23:50:43Z","timestamp":1763077843759},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.transci.2015.11.006","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T14:15:46Z","timestamp":1448460946000},"page":"269-278","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block"],"prefix":"10.1016","volume":"53","author":[{"given":"Amelia","family":"Ruffatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Favaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Brucato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Ramoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Facchinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Tonello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Del Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Calligaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariela","family":"Hoxha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Grava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giustina","family":"De Silvestro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2015.11.006_bib0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2230.1984.tb00856.x","article-title":"The Prosser\u2013White oration 1983. Connective tissue disease and the skin","volume":"9","author":"Hughes","year":"1984","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.transci.2015.11.006_bib0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2015.11.006_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-857X(05)70311-2","article-title":"Hopkins Lupus Pregnancy Center: 1987 to 1996","volume":"23","author":"Petri","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.transci.2015.11.006_bib0025","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.transci.2015.11.006_bib0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"Br Med J"},{"key":"10.1016\/j.transci.2015.11.006_bib0035","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/humrep\/17.11.2981","article-title":"Antiphospholipid antibodies (APA) and recurrent pregnancy loss: a unique APA positive population","volume":"17","author":"Franklin","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.transci.2015.11.006_bib0040","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006250-200209000-00004","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.transci.2015.11.006_bib0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.transci.2015.11.006_bib0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/kep373","article-title":"Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression","volume":"9","author":"Mak","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.transci.2015.11.006_bib0055","first-page":"1442411","article-title":"Combined therapy in pregnancy with primary antiphospholipid syndrome","author":"Szodoray","year":"2003","journal-title":"Orv Hetil"},{"key":"10.1016\/j.transci.2015.11.006_bib0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2006-931805","article-title":"Intravenous immunoglobulin in antiphospholipid syndrome and maternal floor infarction when standard treatment fails: a case report","volume":"23","author":"Chang","year":"2006","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.transci.2015.11.006_bib0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/00016349309013355","article-title":"Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies","volume":"72","author":"Kaaja","year":"1993","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.transci.2015.11.006_bib0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","article-title":"A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group","volume":"182","author":"Branch","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.transci.2015.11.006_bib0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3892\/etm.2012.743","article-title":"Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome","volume":"5","author":"Xiao","year":"2013","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.transci.2015.11.006_bib0080","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1182\/blood-2011-02-339234","article-title":"First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss","volume":"117","author":"Bramham","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.transci.2015.11.006_bib0085","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(87)92584-0","article-title":"Successful removal of anti-phospholipid antibody during pregnancy using plasma exchange and low-dose prednisolone","volume":"2","author":"Frampton","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2015.11.006_bib0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijgo.2007.05.045","article-title":"Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome","volume":"99","author":"El-Haieg","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.transci.2015.11.006_bib0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0897.1999.tb00443.x","article-title":"Immunoadsorption plasmapheresis as a treatment for pregnancy complicated by systemic lupus erythematosus with positive antiphospholipid antibodies","volume":"41","author":"Nakamura","year":"1999","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.transci.2015.11.006_bib0100","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/ard.51.3.399","article-title":"Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy","volume":"51","author":"Kobayashi","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.transci.2015.11.006_bib0105","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.autrev.2006.11.002","article-title":"Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature","volume":"6","author":"Ruffatti","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.transci.2015.11.006_bib0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1744-9987.2009.00671.x","article-title":"Case reports of the use of immunoadsorption or plasma exchange in high-risk pregnancies of women with antiphospholipid syndrome","volume":"13","author":"Bortolati","year":"2009","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2015.11.006_bib0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1160\/TH06-05-0287","article-title":"Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity","volume":"96","author":"Ruffatti","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.transci.2015.11.006_bib0120","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0961203309347794","article-title":"Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome","volume":"19","author":"Bramham","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.transci.2015.11.006_bib0125","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/0961203312451335","article-title":"Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study","volume":"21","author":"Fischer-Betz","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.transci.2015.11.006_bib0130","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.thromres.2008.03.012","article-title":"Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy","volume":"123","author":"Ruffatti","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.transci.2015.11.006_bib0135","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1600-0412.2011.01236.x","article-title":"High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome","volume":"90","author":"Simchen","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.transci.2015.11.006_bib0140","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3899\/jrheum.081194","article-title":"Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus","volume":"36","author":"Danowski","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.transci.2015.11.006_bib0145","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1034\/j.1600-0897.2001.d01-13.x","article-title":"Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis","volume":"46","author":"Carmona","year":"2001","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.transci.2015.11.006_bib0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12016-009-8144-z","article-title":"Predictors of pregnancy outcome in antiphospholipid syndrome: a review","volume":"38","author":"De Carolis","year":"2010","journal-title":"Clin Rev Allerg Immunol"},{"key":"10.1016\/j.transci.2015.11.006_bib0155","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","article-title":"Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study","volume":"50","author":"Ruffatti","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.transci.2015.11.006_bib0160","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1160\/TH14-03-0191","article-title":"Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study","volume":"112","author":"Ruffatti","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.transci.2015.11.006_bib0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jca.21229","article-title":"Plasma exchange and immunoadsorption effectively remove antiphospholipid antibodies in pregnant patients with antiphospholipid syndrome","volume":"27","author":"Bontadi","year":"2012","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2015.11.006_bib0170","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/j.1538-7836.2008.03121.x","article-title":"Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification","volume":"6","author":"Ruffatti","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2015.11.006_bib0175","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2015.11.006_bib0180","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2796.2008.01942.x","article-title":"Plasma exchange for the management of the catastrophic antiphospholipid syndrome: importance of the type of fluid replacement","volume":"264","author":"Marson","year":"2008","journal-title":"J Intern Med"},{"key":"10.1016\/j.transci.2015.11.006_bib0185","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199901213400311","article-title":"Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases","volume":"340","author":"Yu","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2015.11.006_bib0190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-2002-23555","article-title":"Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and\/or anti-La antibodies","volume":"19","author":"Gladman","year":"2002","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.transci.2015.11.006_bib0195","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.20554","article-title":"Outcome of pregnancies in patients with anti-SSA\/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group","volume":"50","author":"Costedoat-Chalumeau","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transci.2015.11.006_bib0200","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.autrev.2005.03.001","article-title":"Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome","volume":"4","author":"Tincani","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.transci.2015.11.006_bib0205","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jacc.2006.07.034","article-title":"Presentation and prognosis of complete atrioventricular block in childhood, according to maternal antibody status","volume":"48","author":"Villain","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.transci.2015.11.006_bib0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/ar1690","article-title":"Anti-SSA\/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options","volume":"7","author":"Costedoat-Chalumeau","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.transci.2015.11.006_bib0215","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multi-racial\/ethnic registry of anti-SSA\/Ro-associated cardiac neonatal lupus","volume":"124","author":"Izmirly","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.transci.2015.11.006_bib0220","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0735-1097(98)00161-2","article-title":"Autoimmune associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry","volume":"31","author":"Buyon","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.transci.2015.11.006_bib0225","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/art.20126","article-title":"Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA\/Ro 52-kd antibodies","volume":"50","author":"Sonesson","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transci.2015.11.006_bib0230","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/CIRCULATIONAHA.108.773143","article-title":"Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA\/Ro-SSB\/La antibodies: a prospective, observational, fetal kinetocardiogram-based study","volume":"119","author":"Rein","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.transci.2015.11.006_bib0235","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1542\/peds.2007-1659","article-title":"Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52\/SSA autoantibodies","volume":"1","author":"Skog","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.transci.2015.11.006_bib0240","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.amjcard.2008.12.027","article-title":"Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study","volume":"103","author":"Friedman","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.transci.2015.11.006_bib0245","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.111.041970","article-title":"Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients","volume":"124","author":"Eliasson","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.transci.2015.11.006_bib0250","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3109\/14767051003728237","article-title":"A management strategy for fetal immune-mediated atrioventricular block","volume":"23","author":"Cuneo","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.transci.2015.11.006_bib0255","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3","article-title":"Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus","volume":"42","author":"Saleeb","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transci.2015.11.006_bib0260","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/art.21152","article-title":"Anti-SSA\/Ro-related congenital heart block in two family members of different generations [Letter]","volume":"52","author":"Ruffatti","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transci.2015.11.006_bib0265","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 2","key":"10.1016\/j.transci.2015.11.006_bib0270","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/AOG.0b013e3181e75a4a","article-title":"Congenital fetal heart block: a potential therapeutic role for intravenous immunoglobulin","volume":"116","author":"David","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.transci.2015.11.006_bib0275","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/AOG.0b013e3182042972","article-title":"Congenital fetal heart block: a potential therapeutic role for intravenous immunoglobulin [Letter]","volume":"117","author":"Brucato","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.transci.2015.11.006_bib0280","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/0961203311430969","article-title":"A combination therapy to treat second-degree anti-Ro\/La-related congenital heart block: a strategy to avoid stable third-degree heart block?","volume":"21","author":"Ruffatti","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.transci.2015.11.006_bib0285","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.autrev.2013.01.002","article-title":"A combination therapy protocol of plasmapheresis, intravenous immunoglobulins and betamethasone to treat anti-Ro\/La-related congenital atrioventricular block. A case series and review of the literature","volume":"12","author":"Ruffatti","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.transci.2015.11.006_bib0290","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3899\/jrheum.080737","article-title":"Congenital heart block not associated with anti-ro\/la antibodies: comparison with anti-ro\/la-positive cases","volume":"36","author":"Brucato","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.transci.2015.11.006_bib0295","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0961203309103188","article-title":"Serological follow-up of children born to mothers with Ro\/SSA autoantibodies","volume":"18","author":"Klauninger","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.transci.2015.11.006_bib0300","doi-asserted-by":"crossref","DOI":"10.1111\/trf.13046","article-title":"Plasma exchange effectively removes 52- and 60-kDa anti-Ro\/SSA and anti-La\/SSB antibodies in pregnant women with congenital heart block","author":"Tonello","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2015.11.006_bib0305","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1191\/0961203302lu173oa","article-title":"Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA\/Ro-SSB\/La antibodies","volume":"11","author":"Askanase","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.transci.2015.11.006_bib0310","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.rdc.2007.02.005","article-title":"Neonatal lupus syndromes","volume":"33","author":"Izmirly","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.transci.2015.11.006_bib0315","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/hc1002.103433","article-title":"Images in cardiovascular medicine. Calcification of the atrioventricular node in a fetus affected by congenital complete heart block","volume":"105","author":"Angelini","year":"2002","journal-title":"Circulation"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050215001858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050215001858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T22:41:14Z","timestamp":1567377674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050215001858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1473050215001858"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2015.11.006","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2015.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}